Outsourcing Next-Gen Therapies Relies on Expertise and Technology: The value of outsourcing partnerships for next-gen biotherapeutics rests in the expertise and technologies that service providers bring to the table.
| Published in: | BioPharm International Vol. 38; pp. 4 - 8 |
|---|---|
| Main Author: | |
| Format: | pictorial Journal Article |
| Published: |
MJH Life Sciences
2025 Special Issue
|
| Online Access: | View this record in EBSCOhost |
| Description not available. |